STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Recruiting
- High Grade Myelodysplastic Syndromes
- Omacetaxine
- Azacitidine
- Aurora, ColoradoUniverstiy of Colorado Denver
2021-10-19
Oct 19, 2021N
Active, not recruiting
- Recurrent Acute Myeloid Leukemia
- Refractory Acute Myeloid Leukemia
- Azacitidine
- Pevonedistat
- Los Angeles, California
- +3 more
2022-03-25
Mar 25, 2022A
Recruiting
- Recurrent IDH1/2 Mutated Glioma
- Azacitidine
- Paris, FrancePitie Salpetriere Hospital
2022-03-28
Mar 28, 2022W
Active, not recruiting
- Myelodysplastic Syndromes
- vosaroxin
- Azacitidine
- Saint Louis, MissouriWashington University School of Medicine
2022-03-23
Mar 23, 2022N
Not yet recruiting
- Acute Myeloid Leukemia
- siremadlin
- +2 more
- (no location specified)
2022-03-29
Mar 29, 2022H
Recruiting
- Myeloid Malignancy
- azacitidine
- Detroit, MichiganHenry ford hospital
2021-12-23
Dec 23, 2021U
Recruiting
- Acute Myeloid Leukemia
- Azacitidine
- Venetoclax
- Aurora, ColoradoUniverstiy of Colorado Hospital
2022-02-15
Feb 15, 2022M
Active, not recruiting
- Large B-Cell Diffuse Lymphoma
- Oral azacitidine
- R-ICE
- Charleston, South CarolinaMedical University of South Carolina
2022-03-31
Mar 31, 2022F
Withdrawn
- Myelodysplastic Syndrome (MDS)
- FF-10501-01
- Azacitidine
- (no location specified)
2021-07-20
Jul 20, 2021G
Recruiting
- Acute Myeloid Leukemia
- Homoharringtonine
- Azacitidine
- NanJing, ChinaDepartment of Hematology, Zhongda Hospital, Medical School of So
2022-03-22
Mar 22, 2022A
Not yet recruiting
- Higher Risk Myelodysplastic Syndrome
- Chronic Myelomonocytic Leukemia
- AMG 176
- Azacitidine
- (no location specified)
2022-01-13
Jan 13, 2022P
Not yet recruiting
- T-cell Lymphoma
- Tucidinostat, Azacitidine combined with CHOP
- (no location specified)
2021-10-09
Oct 9, 2021U
Active, not recruiting
- Acute Myeloid Leukemia
- Azacitidine and Venetoclax
- Aurora, ColoradoUniversity of Colorado Denver
2021-10-12
Oct 12, 2021U
Not yet recruiting
- Myeloproliferative Neoplasm
- BCR-ABL Negative
- Azacitidine
- Venetoclax
- Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
2021-09-29
Sep 29, 2021I
Not yet recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- IMM01
- Azacitidine
- (no location specified)
2021-11-21
Nov 21, 2021S
Not yet recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- Canton, OhioGabrail Cancer Center
2022-03-17
Mar 17, 2022T
Recruiting
- Relapsed/Refractory Peripheral T-cell Lymphoma
- Anti-PD-1 monoclonal antibody
- +2 more
- Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
2021-12-21
Dec 21, 2021U
Recruiting
- Breast Cancer Female
- Breast Cancer Invasive
- Azacitidine
- Chicago, Illinois
- +1 more
2022-01-24
Jan 24, 2022P
Not yet recruiting
- Acute Myeloid Leukemia, Adult
- ADI-PEG 20
- Houston, TexasMD Anderson Cancer Center
2021-08-11
Aug 11, 2021R
Active, not recruiting
- Pancreas Cancer
- Pembrolizumab
- Azacitidine
- New York, New YorkColumbia University Irving Medical Center
2021-10-20
Oct 20, 2021T
Not yet recruiting
- Leukemia, Myeloid, Acute
- +2 more
- venetoclax combining chidamide and azacitidine (VCA)
- (no location specified)
2022-03-23
Mar 23, 2022M
Active, not recruiting
- High Risk Myelodysplastic Syndrome
- +2 more
- Azacitidine
- Pembrolizumab
- Houston, TexasM D Anderson Cancer Center
2021-10-06
Oct 6, 2021G
Not yet recruiting
- Acute Myeloid Leukemia
- Magrolimab
- +3 more
- Houston, TexasMD Anderson Cancer Center
2022-02-03
Feb 3, 2022T
Recruiting
- Patients With Recurrent Acute Myelogenous Leukemia After Transplantation
- CD47 monoclonal antibody
- Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University, Jiangsu Ins
2022-03-03
Mar 3, 2022M
